Clover Health Files 8-K with Financials and Reg FD Update

TL;DR

CLOV filed an 8-K today with financial updates and Reg FD info.

AI Summary

Clover Health Investments Corp. filed an 8-K on October 10, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee, 37067, with a business phone number of (201) 432-2133. The company was incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing provides updated financial information and regulatory disclosures for Clover Health, which is crucial for investors to assess the company's current financial health and compliance status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial statements and a Regulation FD disclosure, not indicating any immediate material adverse events.

Key Players & Entities

• CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
• 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 (location) — Principal Executive Offices
• October 10, 2024 (date) — Date of Report
• Delaware (location) — State of Incorporation
• 001-39252 (other) — Commission File Number

FAQ

Key Financial Figures

• $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market

Filing Documents

• clov-20241010.htm (8-K) — 30KB
• pressreleaseofthecompanyda.htm (EX-99.1) — 12KB
• 0001801170-24-000204.txt ( ) — 172KB
• clov-20241010.xsd (EX-101.SCH) — 2KB
• clov-20241010_lab.xml (EX-101.LAB) — 22KB
• clov-20241010_pre.xml (EX-101.PRE) — 13KB
• clov-20241010_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On October 10, 2024, Clover Health Investments, Corp. (the "Company") issued a press release that the Centers for Medicare and Medicaid Services ("CMS") has increased the Star rating of its PPO Medicare Advantage plans to 4 Stars for 2025, which will affect payment year 2026. In payment year 2026, the Company expects to experience a general 5% quality bonus increase in benchmark rates as a result of its PPO contract being rated 4.0 Stars, in accordance with CMS regulations. Increased quality bonus payments enable the Company to further reinvest in more competitive benefits, which the Company believes will deliver greater value to its members while fueling continued membership growth. A copy of the complete press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Forward-Looking Statements Please note that this Current Report on Form 8-K (the "Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and the Company's future results of operations, financial position, business strategy and future plans. Forward-looking statements are not guarantees of future performance, and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "can," "could," "should," "would," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "outlook," "forecast," "guidance," "objective," "plan," "seek," "grow," "target," "if," "continue" or the negative of these words or other similar terms or expressions that concern the Company's expectations, strategy, priorities, plans or intentions. Forward-looking statements in this Report include, but are not limited to, the anticipated benefits associated with CMS's 2025 Star rating of 4 for the Company's PPO MA plans, as well as our expectations related to the Company's profitability, liquidity, future performance, future operations and future results. These statements are subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this Report. Additional information concerning these and other risk factors is contained in the Company's most recent Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on March 14, 2024, and in our subsequent filings with the SEC, in each case where relevant, including

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press Release of the Company, dated October 10, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Clover Health Investments, Corp. Date: October 10, 2024 By: /s/Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR